Five things for pharma marketers to know: Wednesday, March 29, 2017

A panel recommends the U.S. government license a hepatitis-C therapy; the FDA approves Roche MS drug; new eczema drug to cost $37,000 per year

Patients are taking on DTC ads. How will drugmakers respond?

Pharma spent more than $4 billion on TV ads last year. Empowered patient communities weren't impressed. Has DTC on TV reached its moment of reckoning?

The Top 10 DTC Ads of 2016

The Top 10 DTC Ads of 2016

Mary Skoyles finds that DTC ads are getting better. "There's a lot of interesting work being done," she says. "There are more chances being taken."

The DTC Ads of 2016 That Shouldn't Have Happened

The DTC Ads of 2016 That Shouldn't Have Happened

Pharma marketers are producing plenty of exceptional creative work in the DTC realm. There are also plenty that prompt quick checks to make sure that one hasn't inadvertently clicked over to The Onion.

MM&M's 2017 Agency A-to-Z survey is open

MM&M's 2017 Agency A-to-Z survey is open

The results will be compiled in MM&M's 2017 Agency A-to-Z Directory, the industry's most comprehensive list of healthcare marketing and advertising agencies.



In this sponsored video series, Marc Iskowitz, MM&M's editor in chief, sits down with Tracy Doyle, CEO of Phoenix Marketing Solutions, to discuss healthcare trends and what's on the horizon in 2017.



Senate committee launches investigation into opioid marketing

Senate committee launches investigation into opioid marketing

The committee is seeking information about the companies' sales and marketing strategies.

What doctors have to say about those DTC ads

What doctors have to say about those DTC ads

We had SERMO, a social network for physicians, ask about 1,700 physicians what they have to say about the impact of DTC on patient care and choices. Note: It's not pretty.

The 2017 DTC Report: All the data in one place

The 2017 DTC Report: All the data in one place

Drugmakers again spent more on DTC advertising in 2016 than the year before.

Five things for pharma marketers to know: Tuesday, March 28, 2017

Five things for pharma marketers to know: Tuesday, March 28, 2017

Ovarian cancer drug nabs FDA approval; Senate committee to investigate opioid manufacturers; Allergan's acne drug reports positive Phase-III results

Veeva and QuintilesIMS tussle over customer reference data

Veeva and QuintilesIMS tussle over customer reference data

Veeva is countersuing QuintilesIMS in the wake of allegations that Veeva mishandled its proprietary data.

Five things for pharma marketers to know: Monday, March 27, 2017

Five things for pharma marketers to know: Monday, March 27, 2017

Alexion names former Baxalta head as CEO; U.S. dollar drops after AHCA-fail; EMA advises suspension of 300 generic drugs by Indian drugmaker

P&G exec who led Always #LikeAGirl campaign moves to comms leadership role at Novartis

P&G exec who led Always #LikeAGirl campaign moves to comms leadership role at Novartis

P&G's Mark Chakravarty has joined pharma giant Novartis in a senior role.

Pro Ad Report: All the data on medical journal spending in 2016

Pro Ad Report: All the data on medical journal spending in 2016

The top three most advertised brands in 2016 were Gilead Sciences' Harvoni, Eli Lilly's Trulicity, and J&J's Invokana.

What five different pharma marketing careers look like

What five different pharma marketing careers look like

Five highly placed insiders in a range of roles and therapeutic categories share secrets to their success and advice that served them well along the way.

Five things for pharma marketers to know: Friday, March 24, 2017

Five things for pharma marketers to know: Friday, March 24, 2017

Lilly to invest $850 million in the U.S.; President Trump gives GOP leaders ultimatum on healthcare bill; Pfizer, Merck KGaA receive FDA approval for Bavencio

Five things for pharma marketers to know: Thursday, March 23, 2017

Five things for pharma marketers to know: Thursday, March 23, 2017

AHCA set for vote; J&J halts YouTube ads; approval decisions loom for Sanofi, Roche

Healthgrades' Eric Jensen on providing quality of life

Healthgrades' Eric Jensen on providing quality of life

Healthcare is sometimes about life or death, but is almost always about quality of life, says the EVP of health system products and strategy.

Read the complete March 2017 digital edition

Read the complete March 2017 digital edition

Here you'll find everything you need to know from MM&M's March 2017 issue, including our healthcare marketers trend report, our deep dive into orphan drugs, and more.

Roundtable: How healthcare agencies can retain and attract A-list talent

Roundtable: How healthcare agencies can retain and attract A-list talent

Seven execs from A-list agencies weigh in on talent acquisition and retention.

The 'i's have it for eye-care brand Xiidra

The 'i's have it for eye-care brand Xiidra

The Xiidra marketing team attempted to move away from the standard drug commercial to shine in a new market and challenge legacy techniques.

Agency Spotlight

Featured Listings

OPINION

Gottlieb Likely to Take On Off-Label, Predictability at the FDA

Newsletters